Papers
Topics
Authors
Recent
Search
2000 character limit reached

New developments for ALICE MasterClasses and the new Particle Therapy MasterClass

Published 4 May 2020 in physics.ed-ph and hep-ex | (2005.02215v2)

Abstract: International MasterClasses (IMC), an outreach activity of the International Particle Physics Outreach Group (IPPOG), has been bringing cutting-edge particle physics research to schoolchildren for over 15 years now. All four LHC experiments participate in the event, including ALICE, the experiment optimised for the study of heavy-ion collisions. Heavy-ion physics is actively contributing to IMC with new developments including experimental measurements but also applications for society, such as treatment of cancer with ions. In particular, ALICE provides three MC measurements related to the main observables used to characterize the properties of the produced Quark-Gluon Plasma. Historically, those MC measurements were developed independently, inheriting from the first one, by several ALICE groups. Since all of them are based on the ROOT EVE package, a project to integrate them into a common framework was undertaken. ALICE delivers now a single and easy-to-use application, compiled under Linux, MacOS, and, for the first time, Windows. Then, in line with current IPPOG goals to increase the global reach and scope of the IMC programme a newly developed measurement on medical applications of particle physics, the Particle Therapy MasterClass (PTMC) was introduced in the IMC2020 programme. It is a simplified version of matRad, a MATLAB-based toolkit for calculation of dose deposition in the body and allows for planning of radiotherapy using different modalities and highlighting the benefits of treatment with ions.

Summary

No one has generated a summary of this paper yet.

Paper to Video (Beta)

No one has generated a video about this paper yet.

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.